3054 Stock Overview
Operates in the biomedical science industry in Taiwan and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
LIWANLI Innovation Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$24.80 |
| 52 Week High | NT$25.00 |
| 52 Week Low | NT$19.10 |
| Beta | -0.0018 |
| 1 Month Change | 11.21% |
| 3 Month Change | 9.49% |
| 1 Year Change | 18.66% |
| 3 Year Change | 2.27% |
| 5 Year Change | -9.82% |
| Change since IPO | -88.19% |
Recent News & Updates
Shareholder Returns
| 3054 | TW Tech | TW Market | |
|---|---|---|---|
| 7D | 0% | -0.7% | -0.7% |
| 1Y | 18.7% | 16.9% | 28.8% |
Return vs Industry: 3054 exceeded the TW Tech industry which returned 16.9% over the past year.
Return vs Market: 3054 underperformed the TW Market which returned 28.8% over the past year.
Price Volatility
| 3054 volatility | |
|---|---|
| 3054 Average Weekly Movement | 2.9% |
| Tech Industry Average Movement | 5.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 3054 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 3054's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | n/a | n/a | www.liwanli.com.tw |
LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for male, female, elderly, and children. Its products include anti-aging desire, pro-active nutrients capsules, black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, algae DHA soft gels, shea butter with type II collagen soft gels, algae astaxanthin sQ10 soft gels, cordyceps militaries powder, tooth guard tablets, bovine and goat’s milk bites, bilberry-tablets, DHA and vitamin D3 drops, and other products.
LIWANLI Innovation Co., Ltd. Fundamentals Summary
| 3054 fundamental statistics | |
|---|---|
| Market cap | NT$1.99b |
| Earnings (TTM) | -NT$16.07m |
| Revenue (TTM) | NT$95.94m |
20.8x
P/S Ratio-124.4x
P/E RatioIs 3054 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3054 income statement (TTM) | |
|---|---|
| Revenue | NT$95.94m |
| Cost of Revenue | NT$76.75m |
| Gross Profit | NT$19.20m |
| Other Expenses | NT$35.27m |
| Earnings | -NT$16.07m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.20 |
| Gross Margin | 20.01% |
| Net Profit Margin | -16.75% |
| Debt/Equity Ratio | 0% |
How did 3054 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 15:23 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LIWANLI Innovation Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|